293 related articles for article (PubMed ID: 31197556)
21. Prognostic Value of Lymphovascular Invasion in Node-Negative Upper Urinary Tract Urothelial Carcinoma Patients Undergoing Radical Nephroureterectomy.
Liu W; Zhou Z; Dong D; Sun L; Zhang G
Yonsei Med J; 2019 Feb; 60(2):174-181. PubMed ID: 30666839
[TBL] [Abstract][Full Text] [Related]
22. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
Chung HS; Hwang EC; Kim MS; Yu SH; Jung SI; Kang TW; Choi C; Choi SH; Kwon TG; Noh JH; Kim MK; Cho WJ; Kang SG; Kang SH; Cheon J; Seo IY; Chung H; Kim HS; Lee CH; Ku JY; Ha HK; Kim BH; Jeong CW; Ku JH; Kwak C; Kwon D
Clin Genitourin Cancer; 2019 Jun; 17(3):e394-e407. PubMed ID: 30782419
[TBL] [Abstract][Full Text] [Related]
23. Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration.
Fairey AS; Kassouf W; Estey E; Tanguay S; Rendon R; Bell D; Izawa J; Chin J; Kapoor A; Matsumoto E; Black P; So A; Lattouf JB; Saad F; Drachenberg D; Cagiannos I; Lacombe L; Fradet Y; Jacobsen NE
BJU Int; 2013 Oct; 112(6):791-7. PubMed ID: 23148712
[TBL] [Abstract][Full Text] [Related]
24. Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort study.
Kagawa H; Urabe F; Kiuchi Y; Katsumi K; Yamaguchi R; Suhara Y; Yoshihara K; Goto Y; Sadakane I; Yata Y; Saito S; Kurawaki S; Ajisaka S; Miyajima K; Takahashi K; Iwatani K; Imai Y; Sakanaka K; Nakazono M; Kurauchi T; Kayano S; Onuma H; Aikawa K; Yanagisawa T; Tashiro K; Tsuzuki S; Furuta A; Miki J; Kimura T;
Int J Clin Oncol; 2024 Jan; 29(1):55-63. PubMed ID: 37863996
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
[TBL] [Abstract][Full Text] [Related]
26. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
Kim KH; You D; Jeong IG; Hong JH; Ahn H; Kim CS
Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
[TBL] [Abstract][Full Text] [Related]
27. Impact of body mass index on the oncological outcomes of patients with upper and lower urinary tract cancers treated with radical surgery: A multi-institutional retrospective study.
Murakami Y; Matsumoto K; Ikeda M; Utsunomiya T; Hirayama T; Koguchi D; Matsuda D; Okuno N; Taoka Y; Irie A; Iwamura M
Asia Pac J Clin Oncol; 2018 Aug; 14(4):310-317. PubMed ID: 29356359
[TBL] [Abstract][Full Text] [Related]
28. Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study.
Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YD; Ha YS; Kim TH; Kwon TG; Byun SS; Jeh SU; Kim WJ
J Korean Med Sci; 2017 Feb; 32(2):335-342. PubMed ID: 28049247
[TBL] [Abstract][Full Text] [Related]
29. Pretreatment elevated fibrinogen level predicts worse oncologic outcomes in upper tract urothelial carcinoma.
Xu H; Ai JZ; Tan P; Lin TH; Jin X; Gong LN; Lei HR; Yang L; Wei Q
Asian J Androl; 2020; 22(2):177-183. PubMed ID: 31169138
[TBL] [Abstract][Full Text] [Related]
30. Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.
Kuroiwa K; Inokuchi J; Nishiyama H; Kojima T; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yokomizo A; Matsuyama H; Ichikawa T; Mizusawa J; Eba J; Naito S;
J Urol; 2019 Dec; 202(6):1127-1135. PubMed ID: 31251717
[TBL] [Abstract][Full Text] [Related]
31. High Infiltration of CD163-Positive Macrophages in Intratumor Compartment Predicts Poor Prognosis in Patients With Upper Urinary Tract Urothelial Carcinoma and Radical Nephroureterectomy.
Kobayashi Y; Arai H; Hamamoto Y; Yoshida K; Shimizu S; Yasuhara Y; Ichimaru N
Clin Genitourin Cancer; 2023 Oct; 21(5):e386-e393. PubMed ID: 37244798
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the Clinical Utility of Renin-Angiotensin System Inhibitors in Patients Undergoing Radical Surgery for Urothelial Carcinoma of the Upper Urinary Tract.
Yoshida T; Matsuzaki T; Murota T; Kawa G; Matsuda T; Kinoshita H
Clin Genitourin Cancer; 2017 Dec; 15(6):e943-e954. PubMed ID: 28552573
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis.
Quhal F; Mori K; Sari Motlagh R; Laukhtina E; Pradere B; Rouprêt M; Necchi A; Moschini M; Shariat SF
Int J Clin Oncol; 2020 Jun; 25(6):1037-1054. PubMed ID: 32206939
[TBL] [Abstract][Full Text] [Related]
34. Impact of surgical wait time on oncologic outcomes in upper urinary tract urothelial carcinoma.
Lee JN; Kwon SY; Choi GS; Kim HT; Kim TH; Kwon TG; Kim BW
J Surg Oncol; 2014 Sep; 110(4):468-75. PubMed ID: 25059848
[TBL] [Abstract][Full Text] [Related]
35. Effect of Lymphadenectomy During Radical Nephroureterectomy in Locally Advanced Upper Tract Urothelial Carcinoma.
Ikeda M; Matsumoto K; Sakaguchi K; Ishii D; Tabata KI; Kurosawa K; Urakami S; Okaneya T; Iwamura M
Clin Genitourin Cancer; 2017 Oct; 15(5):556-562. PubMed ID: 28501481
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma.
Zhang XK; Zhang ZL; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
Jpn J Clin Oncol; 2015 Nov; 45(11):1069-75. PubMed ID: 26355163
[TBL] [Abstract][Full Text] [Related]
37. Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinoma.
Singla N; Christie A; Freifeld Y; Ghandour RA; Woldu SL; Clinton TN; Petros FG; Robyak H; Yeh HC; Fang D; Enikeev D; Bagrodia A; Sagalowsky AI; Lotan Y; Raman JD; Matin SF; Margulis V
Urol Oncol; 2020 Dec; 38(12):933.e7-933.e12. PubMed ID: 32430254
[TBL] [Abstract][Full Text] [Related]
38. Noninferior oncological outcomes in adults aged 80 years or older compared with younger patients who underwent radical nephroureterectomy for upper tract urothelial carcinoma.
Yamada Y; Ikeda M; Hirayama T; Murakami Y; Koguchi D; Matsuda D; Okuno N; Taoka Y; Utsunomiya T; Irie A; Matsumoto K; Iwamura M
Asia Pac J Clin Oncol; 2023 Jun; 19(3):305-311. PubMed ID: 35909301
[TBL] [Abstract][Full Text] [Related]
39. Transperitoneal radical nephroureterectomy is associated with worse disease progression than retroperitoneal radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
Kim TH; Suh YS; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Sung HH
Sci Rep; 2019 Apr; 9(1):6294. PubMed ID: 31000756
[TBL] [Abstract][Full Text] [Related]
40. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
